AVXL R&D Expenses
Anavex Life Sciences Corp · R&D Expenses
AVXL R&D Expenses
Latest reported$20.29Mperiod ending
AVXL TTM R&D Expenses ($0.00 → $20.29M)
TTM R&D Expenses
High-resolution chart · PNG
AVXL r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 20,286,000 | |
| 26,101,000 | |
| 31,801,000 | |
| 37,591,000 | |
| 41,852,000 | |
| 43,704,000 | |
| 43,541,000 | |
| 41,779,000 | |
| 40,284,636 | |
| 38,756,636 | |
| 39,584,636 | |
| 42,967,636 | |
| 44,288,450 | |
| 43,278,719 | |
| 41,326,308 | |
| 37,915,747 | |
| 35,907,083 | |
| 35,598,342 | |
| 33,714,594 | |
| 32,983,674 | |
| 29,715,794 | |
| 27,476,266 | |
| 26,808,472 | |
| 25,231,621 | |
| 23,837,622 | |
| 22,871,068 | |
| 22,896,807 | |
| 22,260,349 | |
| 21,956,894 | |
| 19,196,082 | |
| 16,362,319 | |
| 13,344,421 | |
| 12,773,355 | |
| 12,075,998 | |
| 11,323,908 | |
| 10,672,086 | |
| 11,174,571 | |
| 10,033,114 | |
| 8,630,708 | |
| 7,751,896 | |
| 4,159,528 | |
| 3,800,170 | |
| 3,116,789 | |
| 2,271,736 | |
| 1,869,281 | |
| 1,334,834 | |
| 1,045,840 | |
| 732,395 | |
| 485,610 | |
| 259,616 | |
| 142,024 | |
| 263,847 | |
| 279,541 | |
| 634,483 | |
| 1,063,530 | |
| 2,653,860 | |
| 3,132,679 | |
| 3,516,687 | |
| 3,817,322 | |
| 2,597,279 | |
| 3,094,090 | |
| 2,929,280 | |
| 3,014,647 | |
| 2,728,836 | |
| 2,711,397 | |
| 2,553,919 | |
| 2,067,169 | |
| 2,139,794 | |
| 1,853,180 | |
| 1,645,729 | |
| 1,540,436 | |
| 1,551,482 | |
| 1,661,150 | |
| 1,452,871 | |
| 1,254,848 | |
| 959,698 | |
| 65,496 | |
| 25,543 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |